equol has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidayah, K; Lin, CI; Lin, SH; Tsai, MC | 1 |
| Bothwell, R; Burns, JM; Jackson, RL; Koppel, S; Mahnken, JD; Swerdlow, RH; Welch, P; Wilkins, HM | 1 |
2 other study(ies) available for equol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Equol Pretreatment Protection of SH-SY5Y Cells against Aβ (25-35)-Induced Cytotoxicity and Cell-Cycle Reentry via Sustaining Estrogen Receptor Alpha Expression.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin D1; Equol; Estradiol; Estrogen Receptor alpha; Gene Expression; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Peptide Fragments; Phytoestrogens | 2019 |
A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Electron Transport Complex IV; Equol; Female; Follow-Up Studies; Humans; Middle Aged; Mitochondria; Phytoestrogens; Pilot Projects; Treatment Outcome | 2017 |